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The role of Langerhans cells (Le) in host resistance against 
the induction and growth of nonmelanoma skin cancerS is 
sti11 obscure. The purpose of this study was to investigate the 
sensitivity of LC to simulated solar radiation in patients with 
basal cell carcinoma (BCe). Thirty-four patients (31- 74 
years old) with ac least one histologically diagnosed BCC on 
a sun-exposed arca and 21 healthy volunteers (29 -62 years 
old) were included in the study. Patients and control subjects 
were given 10 graded doses of simulated solar UV rad.iation 
(10- 75 mJ/cm') on the lower back using a 12S solarsimula-
tor with a WG 320 filter. Twenty-four hours later, the mini-
mal erythema dose (MEO) was determined and shave biop-
sies were taken from the site given 1.25 X MED and from 
adjacent. unirradiated skin. Epiderrna1 sheets were stained for 
LC using the ATPase method. The mean value of the MED 
of the BCC patients was 25 ± 2 mJ/cm' and that of controls 
was 29 ± 3 mJ/ cm' (p > 0.05). The number of ATPase+ LC 
B asaJ cell carcinoma (BeC) is the most common type of cancer in the United States today [t J. It occurs on sun-exposed skin in the majority of patients, and ultraviolet radiation (UVR) is considered to be the mos t frequent factor associated with induction of this cancer. In addi-
tion to its direct carcinogenic effect, UVR also affects the immune 
system [2J. The immulloiogiceifects ofUVR play an imr0rtanr role 
in the pathogenesis of skin cancers in murine systems {3 . It is there-
fore possible that the devdopment and growth of BCe in humans is 
also influenced by the effect of UVR on immunologic processes. 
In recent years ir was found that the skin serves as the most 
peripheral outpost of the immune system. One of the key 6ndings 
was. that Langerhans cell'!> (LC). dendritic cells tbat reside in the 
epidermis. playa role in CUtaneous immunologic reactions as a result 
of their antigen-presenting capacity 14). LC may also interact with 
neighboring keratinocytes. which secrete immunoregulatory cyro-
kines [5J. An additional . important observation was thar UVR, 
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was significantly decreased (p < 0.05), and their morphol-
ogy was altered in the irradiated skin of nearly all individuals. 
However, there was no significant difference in the average 
reduction of LC in the patients (32% ± 3%) compared with 
that of control subjects (32% ± 4%). The depletion of LC 
ranged from 0% to 74% in clifferent individuals, all of whom 
were given 1.25 MED. Furthermore, no correlation was 
found between [he percentage decrease in ATPase+ cells and 
the dose ofUV radiation required to produce erythema. OUf 
results indicate that the ability of UV radiation to cause ery-
thema was unrelated to the magnitude of its effects on LC 
nurnberor morphology. Second. the morphologic alterations 
ofLC in BCC patients after UV irradiarion do not differ from 
those observed in normal ind.ividuals. Third, as a group, pa-
tients with Bee do not have a significantly lower MED than 
cancer-free subjects.} [,west DennalOl 93:746 - 750, 1989 
mainly in the UVB (280- 320 nm) range, decreased the number of 
LC. al tered their mo~hology. and interfered with their antigen-
presenting capacity [6J. 
The role o( Le in immune surveillance against the induction and 
growth of skin cancer is still unknown. It is unclear whether deple-
tion of LC or alteration of theit morphology contributes to the 
dcvdormcm of skin cancer. To obtain a better understanding of the 
role 0 LC in cutaneous immunity against BCC, we set out to 
detennine whether patients who develop BCC are more prone to 
modification of their LC by UVR than are normal subjects who do 
not have BCC. to this report we present evidence indicating that 
DCC patients do not differ from cancer-free patients in the response 
of their LC to UVR. 
MATERIALS AND METHODS 
Patients Thirty-four patienrs, 24 men and 10 women aged 31 - 74 
years, took parr in tne study. Each patient had at least one Bee on 
sun-exposed skin in the past. The diagnosis of Bee was confirmed 
histologically after the removal of the tumor by Mohs micrographic 
surgery. 
Twenry.one healthy volunteers, 16 women and five men aged 
29 - 62 years, served as the comparison group. Each volunteer was 
examined carefully co exclude the presence of Dec. Both rhe 
cancer patients and canccr· free individuals were Texas residents for 
at least 5 years prior to tbe study. 
All patients were asked to supply a history of their reactivity to 
sun exposure and tanning ability and were classified into sk.in types 
acco rd.ing to the system of Fitzparrick [7J. Informed consent was 
obtained from all parricipants. 
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Radjation Source The radiation source was a 150 W xenon arc 
sobr VV simulator modell2S (Solar Light Co., Philadelphia, PAl 
with a 1-mm Schott WG 320 filter, which eliminates the lamp's 
wavelengths below 295 nm. A SO-em liquid light guide was con-
nected to the solar simulator, and intensity measurements were 
taken at the end of the guide using a 3D detector (Solar Light Co.). 
ExperimentaJ Protocol All subjects were irradiated on the lower 
back. The liqujd light guide was arrached to the skin. and a circular 
area 1 cm in diameter was exposed . .Each individual received 10 
graded doses of UV radiation starting at 10 mJ /cm2 with 25% 
increment". The minimal erythema dose (ME D) was defined 24 h 
later as the lowest dose that produced faint bUl visible redness. Then 
shave biopsies were uken from the site exposed to 1.25 X MED and 
from adjacent unexposed skin . .Each specimen was placed immedi-
ately in Hank's balanced salt solmion and prepared for ATPase 
staining. 
ATPase Staining foe LC The epidennis was separated from the 
dermis after a 2- 3-h incubation at 37 · C in buffered EDTA [8J. The 
t"pidermal sheets were fixed overnight at 4"C in 0.05 M cacodylate-
2% paraformalde.hyde solution. The samples were' washed wirh 
0 .15 M NaCI and incubated at 3rc for 40 mit' with a solution 
con taining ATP powder, Tris-Mal , MgS04. and Pb(NO))2' and 
then again in 0.15 M N aCI and immersed for 60 sec in (NH")2S. 
The stained specimens were mounted in glycerol: PHS (9: 1. v/ v) 
on glass sl ides. 
The number of ATPase+ cd ls in every specimen ...... as detennined 
by the same observer using a Nikon Optiphor microscope (Nikon 
Inc .. Garden City. NY) with a calibrated ocular grid. Berween 10 
and 20 fields were counted from each specimen. The data were 
expressed as rhe number of dendriric. ATPase+ cells/ mm1 epi-
dermis. Percenr depiction of LC in each individual was calculated as 
follows: 
( I - # LC irradiated ) X 100. ft: LC unirradiated 
Statistical Analysis T ests for normaliry were done on rhe popula-
tions usin g rhe program PROe Univariare in SAS [91. Because the 
sample sizes were less than 51. the Shapiro-Wilk statistic. W, was 
computed. The null hypothesis for the W -statistic was that the data 
va lues were a random sample from a nonnal distribution. For our 
sample population tht" null hypochesis was not rejecred . Because the 
assumption for computing a t-teSf had betn Illet (i.e .• random sam-
ple. nonnally distributed, and a sample size of approxi mately 30 or 
less) BMDP 3D 1101 was used to compare all the Hests. The F 
statistic for the Levene equality of variance tesc was performed in the 
BMDP 3D program. If thc hypothesis of equality of variance was 
nor rejected then the pooled variance T statisric was used. Other-
wise lhe separate variance T statistic was used to [est the hypmhesis 
of equal means. The mean and standard error of the mean of the 
number of LC were determined for each biopsy site. Student's (Wo-
rail ed [-test was used to compare differences in the numbers ofLC in 
irrad ia ted and unirradiated skin in each individual. Th(' same test 
was performed ro compare the number of LC and the MED in 
p.niencs and comparison subjects. Spearman's correlation test was 
used to compare the MED and reduction in the number o f LC. 
RESULTS 
The distribution of the MED of the patients and the comparison 
subjects are shown in Fig 1. We found no statisdcally significant 
differencc (p = 0.2) between the mean MED of the BCC patients 
(25 ± 2 mJ jcm') and that of the cancer-fr« subjccts (29 ± 3 mJ j 
em2). When both groups were divided according to skin type. there 
was no significant difference between the mean MED of the pa-
tients and comparison subjects for skin type III (Table I), which was 
the most common. Using anormaliry test for variables such as age, 
number of cells in irradiated and un,irradiated sites. :lOd percentage 
of depletion of LC. we found that these were normally distributed 
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Figur~ I . The distribution of tht' minimal c=rythema dose (MEO) among 
Ihe cancer ~tients (A) and cancer-free subjects (B). 
in both the cancer group and the cancer-free individuals. There was 
no difference between the median age of rhe cancer patients and that 
of the cancer-free individuals. 
The effect of 1.25 X MED on the number of LC in BCC patients 
and control subjects is ill ustrated in Tables 11 and III , Four patients 
(Nos. 8, I I. 23. 28) and 2 control subjects (Nos. 9 and 12) showed 
no significant depletion (p > 0.05) or alteration of the morphology 
Table 1. Mean MED in B2sal Cdl Carcinoma Patiellts and 
Normal Individuals According to Skin Type 
Me:!.n MED ± SEM (mJ/ cm1)-
Skin Type Bee Patients (n) Non-BCC Puic=nts (n) 
1 19±5 (3) 13± 1 (4) 
II 21±2(14) 20 ± 4 (3) 
p' 
III 27 ± 3 (14) 32±4(1I) 0.4 
IV 33 ± 4 (3) 48 ± 6 (3) 
• MED was dr:ll~rnuned 24 h aftt'r Irradiation .u the lowest dose dUI produCt'd hinl 
but Visible erythema. 
i Probl bility of no differCl1ce, dClcrnuncd by Student's I-test. 
I 
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T.ble D. Number of Langerhans Cells in Irradiated and 
Unirradiared Skin in Basal edt Carcinoma Patients 
Num~r o( langerbans Cells 
(Mean ± SEM) 
No. Unirndi.ued Jrn.diued Percent depletion 
I 1097 ± 48 670 ± 45 39 
2 952 ± 39 832 ± 26 13 
3 1202 ± 54 317 ± 23 74 
4 987 ± 45 767 ± 46 22 
5 1117±26 872± 56 22 
6 834 ± 51 713 ± 33 15 
7 1040 ± 34 450± 33 57 
8 1059 ± 68 982 ± 31 7 
9 1075±41 841 ± 78 22 
10 1060 ± 26 627 ± 65 41 
11 1020 ± 56 900 ± 66 12 
12 897 ± 47 620± 48 31 
J3 937 ± 46 637 ± 56 32 
14 105 ± 66 397 ± 35 44 
15 1169±48 872 ± S6 25 
16 1082 ± 40 925 ± 62 15 
17 J187±45 617 ± 68 48 
18 1052 ± 33 325 ± 54 69 
19 1125±49 1180±36 0 
20 1142±44 807 ± 89 29 
21 1107±58 672 ± 101 39 
22 1147 ± 29 552 ± 68 52 
23 1022 ± 32 959 ± 33 6 
24 900 ± 34 577 ± 78 36 
25 972 ± 51 635 ± 52 35 
26 985 ± 39 772 ± 51 22 
27 1017 ± 33 265 ± 81 74 
28 862 ± 43 794 ± 44 8 
29 855 ± 40 625 ± 48 27 
30 890 ± 38 545 ± 43 39 
31 915 ± 40 732 ± 48 20 
32 1137±17 970 ± 66 15 
33 897 ± 32 308 ± 54 66 
34 957 ± 43 507 ± 64 47 
Table ID. Number of Langerhans Cells in Irradiated :md 
Unirradiared Skin of Cancer-Free Patients 
Number of ungerhans Cells 
(M<an±SEM) 
No. Unirradiated lrradiated Percenf depletion 
I 1097 ± 48 670 ± 45 39 
2 972 ± 29 517 ± 43 47 
3 1092 ± 37 782 ± 34 28 
4 1225±33 995 ± 93 19 
5 11 22 ± 38 935 ±60 17 
6 957 ± 18 592 ± 38 38 
7 760± 50 291±41 62 
8 889 ± 29 582 ± 33 35 
9 872± 34 827 ± 42 5 
10 1137±47 407 ± 62 64 
11 800 ± 37 472 ± 49 41 
12 1035 ± 66 1085 ± 33 0 
13 950 ± 45 800 ± 45 16 
14 1250 ± 49 777 ± 80 38 
IS 772 ± 51 458± 31 41 
16 920 ± 29 650 ± 31 29 
17 872 ± 39 640± 80 27 
18 745 ±4Q 407 ± 4() 45 
19 1022±41 773 ± 28 24 
20 1005 ± 55 670± 51 33 
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of LC at the irradi:ncd site. One control subject rc:fused 2. biopsy. 
The remaining patients (Table II) and cancer-free subjects (Table 
Ill ) exhibited a signinc:mt decrease in the number of LC in skin 
given 1.25 )( MED compared to that in an adjacent, unirradiated 
site. However. when we compared the mean percent depletion of 
LC in the Bee patients (32% ± 3%) to that in heaLthy voLunt~rs 
(32% ± 4%) we found no statistically significant difference. The 
distribution of ptrcentage depletion of LC in boch populations is 
shown in Fig 2. 
W e found no significant difference between the numbe.rs of LC 
in irradiated and unirradiated sites and petcent depletion of these 
cells when we compared males and females in the cancer group and 
the non-canccr group. The same was found when we compared 
males or females in the cancer group to males or females in the 
cancer-free- group. 
There was also no correlation between the percentage depletion 
ofLCand the MED in either group (Fig 3). This result indicates that 
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Figure 2. The disrributiotl of [he percellt ckplclion o( Langerhans cells 
among rhe BCC patients (A) and cancer~free su~ectS (B). Percclluge 
depletion -- (1 - {# of LC in irndiated siteJ# 0 LC in unimdiated 
s;teJ) X 100. 
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Figure 3. Pcrccnrngc depiction of Langerh2ns cells plotted 2gai,nst the 
minimal eryrhcm2 dose (MED) ofllCC p;uic.nts (A) and C2nccr-frct' parients 
(8). N o correlation was found between the amount of depletion 2nd MED. 
individuals who have the saine MED do not necessarily have LC 
with the SJme sensitivity ro UVR. In addition. sinlilar morphologic 
alterations of LC were seen in Bee paricms and cancer-free indi-
viduals after irradiation. These included heavily stained cells, huge 
cells, and dysdendritic cell s (Fig 4). 
DISCUSSION 
An individual's risk of devdoping sunlight-associated skin cancer 
depends on both environmental and host factors. Vitalino and Ur-
bach lIhowed that the inability to tan is the most importam single 
risk facror for BCe 111]. Preliminary data suggested that genetic 
factors, some of which regulate immune tesponses. may also be 
important in patients with BeC [12]. We were interested in deter-
mining whether impairment of local immune ce lls in the skin by 
UVR is an additional risk factor for developing skin cancer. LC are 
epidermal immune cells that are known to be modified following 
UVR exposure. We asked whether LC in patients who have devel -
oped nonmelanoma skin cancer are more susceptible to alteration by 
UVR than the LC in noncancerous individuals. Our srudy demon-
strated that alrhougb most Bee patients exhibited significant de-
piction of ATPasc+ LC after 1.25 X MED of simulated solar radia-
tion, the extent of depletion did not differ significantly from that 
observed in cancer-free subjects. However, an important observa-
tion was that this small amount of UVR was sufficient to signifi-
cantly decrease the number of LC in the epidermis of most subjects. 
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In other studies, higher doses of UVB radiation were required to 
deplete LC from human skin/ but these studies did nor employ 
simulated solar UVR 113.14]' The lack of correlation among differ-
ent individuals between the dose of UVR required to produce 1 
MED and the amount of depletion of LC suggest that erythema and 
loss of ATPase from LC are distinct and unrelated effects of UVR. 
The average- MED of Bee patients and cancer-free subjects did 
not differ significan.t1y. These results support the findings of Tan-
enbaum et a!. who also found no difference in MED between skin 
cancer and control groups using a high-pressure mercury arc lamp 
[1 5}. These findings in nonmclanoma skin cancer patients are inter-
esting in light of a recent study showing that the MED was signifi-
candy lower among patients with malignam melanoma than con-
trols [16]. 
In condusion. we demonstrate that epidermal LC are perturbed 
in Bee patients and cance.r-free individuals after exposure to 
1.25 X MED of simulated solar radiation. However. the magnitude 
of this perturbation is highly variable among individuals and. on the 
average. does nOt differ from thar seen in Bee patients and cancer-
free individuals. Thus, we found no increase in th e: sensitivity of 
human LC to UVR associated with the occurrence of Bee. 
W e tha,,!' Ms. Mary Ann G rl'gllrirh jilr help in th~ slatutical analysis and MJ. 
D (I /I1il/iqllf [)eVil'S Jor hrlp i" preparing this manuscript. 
Figure • . Photomicrograph of ATPa!lc+ ungerham cells in irr::ldiated (A) 
2nd unirradiated (B) skin of Bee patient. 
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BLOOM'S SYNDROME REGISTRY ANNOUNCEMENT 
The Bloom's Syndrome Registry has accumulated genetic and dinical information con-
cerning bona fide instances of Bloom's syndrom e (BS) since the c=arly 19605. Almost 150 
persons with BS have been accessioned to the Registry, probably the vast m ajority of those ever 
diagnosed anywhere in the world. Progress reports from the Registry are published periodically 
(Clio Genet 35:57 - 69, 1989). Besides defining t h is very rare clinical syndrome, this project has 
documented the enormous cancer predisposi tio n of affected homozygotes, and bas shown that 
the cancers are o f diverse types and sites. Samples of serum. erythrocytes, lymphocytes, a nd 
various sources of DNA from affected famil ies h ave been collected and are stored ftozen at The 
New York Blood Center, as are culrured cell lines. 
The accession of new cases to the Registry w ill cease as of January 1~ 1991. Thereafter, 
th e families in (he Registry as of that date will be followed, as in the past, either through the 
referring physician/ geneticist or w ith the f2mil y directly. In order r:o make the cohort of 
affected persons to be followed as I~rge as possible, tbe Registry requests informatioD 
during 1990 abou t any persoDs known to have BS but who are not already in [he Registry . 
Note: If confirmation of t he d iagnosis is required, blood samples from patiems will be accepted 
withom charge for sister-ch romatid exchange (SeE) analysis . Please contact t he fo llowing: 
Laboratory of H uman Genetics, The New York Blood Center, 3 10 EaSt 67th Street, New 
York, NY 10021. Tel. 212/ 570-3075; Fax, 212/570-3195. 
